SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CAI

Caris Life Sciences, Inc.
NASDAQHealth Care

Latest close: 30.56 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 22, 2026Reported sale · Form 4John Russel Denton, See Remarks · $238.6KOpen the filing ↗
  2. Sep 22, 2026Notice of sale · Form 144JOHN RUSSEL DENTON · Officer · $238.6KOpen the filing ↗
  3. Sep 17, 2026Reported sale · Form 4Brian J Brille, See Remarks · $12.1MOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record11418 flagged findings
Reported transactions (Form 4)68since Feb 27, 2025 · and 40 other holdings
Corporate events (8-K)3since Apr 2, 2026

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-08-05share offering or dilution eventfreshOpen filing ↗
    “…ended June 30, 2026 of $7.3 million. The Company recorded a $25.2 million loss on debt extinguishment for the three months ended…”
    +1 more passage from the same document
    • “…months ended June 30, 2026 of $7.3 million. The Company recorded a $25.2 million loss on debt extinguishment for the six months…”
  • 2026-08-05capital return (buybacks/dividends)freshOpen filing ↗
    “…vote of the Company's shareholders. Common shareholders are entitled to receive dividends if and when declared by the Company's board…”
    +1 more passage from the same document
    • “…of any preferred stock then outstanding and compliance with our contractual obligations. No dividends have been declared or paid…”
  • 2026-08-05regulatory investigationfreshOpen filing ↗
    “…our internal control over financial reporting identified during the period covered by this Quarterly Report on Form 10-Q that has…”
  • 2026-08-05Department of Justice inquiryfreshOpen filing ↗
    “…during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to…”
  • 2026-05-08capital return (buybacks/dividends)recentOpen filing ↗
    “…2,800,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 284,262,436 and 284,137,810 shares issued as of…”
    +1 more passage from the same document
    • “…) ( 2,689 ) Net cash used in investing activities ( 10,342 ) ( 2,689 ) Cash flows from financing activities Payments made on…”
  • 2026-05-08regulatory investigationrecentOpen filing ↗
    “…our internal control over financial reporting identified during the period covered by this Quarterly Report on Form 10-Q that has…”
  • 2026-05-08Department of Justice inquiryrecentOpen filing ↗
    “…during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 114)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

114 filings on record, the oldest from Jul 5, 24.

Listing the 25 most recent filings of the 114 on record.

8-Ks, explained

Structure3
  • Apr 2, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • David D. Halbert44.1%Jun 30, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • FMR LLC10.8%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • J H Whitney VI LP7.3%Jun 30, 25SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • J H Whitney VI L P4.0%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Alan Waxman2.6%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
show one more holderhide
  • Millennium Management LLC1.3%Jun 17, 25SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Sep 22, JOHN RUSSEL DENTON filed notice of intent to sell up to $239K.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $239K on Sep 22, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+6 more recent notices · 3 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 22, 26Sell$239KJohn Russel DentonSee Remarks↗
  • Sep 17, 26Sell$12.1MBrian J BrilleSee Remarks↗
  • Sep 4, 26Sell$3.0MDavid Baxley SpetzlerPresident↗
  • Sep 3, 26Sell$9.7MDavid Baxley SpetzlerPresident↗
  • Sep 3, 26Sell$2.1MDavid Baxley SpetzlerPresident↗
  • May 15, 26Buy$990KJON HALBERT↗
  • May 11, 26Buy$501KJeff L Vacirca↗
Stock compensation, tax and giftsshow the 33 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 17, 26Compensation$976KBrian J BrilleSee Remarks↗
  • Sep 4, 26Compensation$610KDavid Baxley SpetzlerPresident↗
  • Sep 3, 26Compensation$2.4MDavid Baxley SpetzlerPresident↗
  • Aug 14, 26Compensationamount n/aJON HALBERT↗
  • Aug 14, 26Compensationamount n/aLAURA I JOHANSEN↗
  • Aug 14, 26Compensationamount n/aPETER M CASTLEMAN↗
  • Aug 14, 26Compensationamount n/aT DANNY PHILLIPS↗
  • Aug 14, 26Compensationamount n/aJoseph E Gilliam↗
  • Aug 14, 26Compensationamount n/aJeff L Vacirca↗
  • Aug 14, 26Compensationamount n/aLloyd Minor↗
  • Aug 14, 26Compensationamount n/aDavid Paul Fredrickson↗
  • May 29, 26Compensation$25KGEORGE POSTE↗
  • May 29, 26Compensation$25KJonathan Kenneth Charles Knowles↗
  • May 15, 26Tax$621KDAVID D HALBERTSee Remarks↗
  • May 15, 26Tax$92KJohn Russel DentonSee Remarks↗
  • May 15, 26Tax$211KDavid Baxley SpetzlerPresident↗
  • May 15, 26Tax$213KBrian J BrilleSee Remarks↗
  • May 15, 26Tax$149KLuke Thomas PowerSee Remarks↗
  • Mar 6, 26Compensationamount n/aDAVID D HALBERTSee Remarks↗
  • Mar 6, 26Compensationamount n/aJohn Russel DentonSee Remarks↗
  • Mar 6, 26Compensationamount n/aDavid Baxley SpetzlerPresident↗
  • Mar 6, 26Compensationamount n/aBrian J BrilleSee Remarks↗
  • Mar 6, 26Compensationamount n/aLuke Thomas PowerSee Remarks↗
  • Feb 26, 26Compensation$50KJON HALBERT↗
  • Feb 26, 26Compensation$111KPETER M CASTLEMAN↗
  • Feb 26, 26Compensation$75KT DANNY PHILLIPS↗
  • Feb 26, 26Compensation$50KJeff L Vacirca↗
  • Feb 26, 26Compensation$50KDavid Paul Fredrickson↗
  • Feb 26, 26Compensation$50KLloyd Minor↗
  • Jan 9, 26Compensation$47KPETER M CASTLEMAN↗
  • Dec 11, 25Giftamount n/aBrian J BrilleSee Remarks↗
  • Dec 11, 25Compensation$60KLuke Thomas PowerSee Remarks↗
  • Dec 11, 25Compensation$92KLuke Thomas PowerSee Remarks↗

The full record holds 80 transactions and goes back to Feb 27, 25.

Its sector and its market

Caris Life Sciences, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Caris Life Sciences, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Caris Life Sciences, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
114 documents on file, from Jul 5, 2024 to Sep 23, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Caris Life Sciences, Inc. (CAI): stock price history, insider trades and SEC filings — HornScout